Case Report
Copyright ©The Author(s) 2019.
World J Clin Cases. Oct 26, 2019; 7(20): 3364-3371
Published online Oct 26, 2019. doi: 10.12998/wjcc.v7.i20.3364
Figure 1
Figure 1 Imaging findings of the patient. A: Pre-chemotherapy magnetic resonance imaging (MRI) scan showed a solid mass located in cervical canal of uterus, suspected involvement of rectal wall; B: Thicken gastric wall was suspected malignant on computed tomography (CT) scan; C: Postchemotherapy MRI scan showed a decrescent solid mass located in cervical canal of uterus; D: Abnormal fluorodeoxyglucose uptake in the cervix uterus, uterine cavity, right adnexa as well as in the stomach on positron emission topography/CT scan.
Figure 2
Figure 2 Histopathological and immunohistochemical staining findings. A: Poorly differentiated endocervical adenocarcinoma; B: Positive stain for Syn; C: Metastatic adenocarcinoma of rectal wall; D: Diffuse atypical hyperplasia in endometrium with focal highly differentiated endometroid adenocarcinoma; E: Positive stain for ER; F: Endometroid adenocarcinoma in right ovary; G: Highly to moderately differentiated adenocarcinoma in stomach; H: Positive stain for Her-2; I: Metastatic adenocarcinoma in perigastric lymph node.